Literature DB >> 6424958

Etiological spectrum of viral hepatitis and prevalence of markers of hepatitis A and B virus infection in north India.

B N Tandon, B M Gandhi, Y K Joshi.   

Abstract

The etiological spectrum of viral hepatitis and the prevalence of serological markers of hepatitis A and B virus infection in healthy persons in north India were studied. Hepatitis A virus was found to be the most common cause of acute hepatitis in children (67%). It was a less frequent cause of this disease in adults (14%). Hepatitis A virus was only rarely the cause of acute (12%) and subacute (4%) liver failure. It was recorded as the etiological agent in an epidemic among schoolchildren. Exposure to hepatitis A virus occurs in early childhood, and by the age of 10 years, 90% of healthy persons have serological evidence of hepatitis A virus infection.Hepatitis non-A non-B virus was the cause of acute hepatitis in 44% of adults and 24% of children with this disease. This virus was also the most important etiological agent in acute liver failure (55%) and subacute hepatic failure (51%). It was the cause of all the hepatitis epidemics in the general population.Only 9% of hepatitis cases in children were due to hepatitis B virus whereas 42% of cases in adults were attributable to this virus. Hepatitis B virus was the causative agent in 33% of cases of acute hepatic failure and 45% of cases of subacute hepatic failure. The carrier rate for hepatitis B virus was 5% and antibody to hepatitis B surface antigen was found in up to 38% of specific population groups.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6424958      PMCID: PMC2536267     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  14 in total

1.  Chronic liver disease after acute non-A, non-B viral hepatitis.

Authors:  J Rakela; A G Redeker
Journal:  Gastroenterology       Date:  1979-12       Impact factor: 22.682

Review 2.  Hepatitis A virus infection: new insights from seroepidemiologic studies.

Authors:  J L Dienstag; W Szmuness; C E Stevens; R H Purcell
Journal:  J Infect Dis       Date:  1978-03       Impact factor: 5.226

3.  The prevalence of antibody to hepatitis A antigen in various parts of the world: a pilot study.

Authors:  W Szmuness; J L Dienstag; R H Purcell; C E Stevens; D C Wong; H Ikram; S Bar-Shany; R P Beasley; J Desmyter; J A Gaon
Journal:  Am J Epidemiol       Date:  1977-11       Impact factor: 4.897

4.  Hepatits A virus infection in fulminant hepatitis and chronic active hepatitis.

Authors:  J Rakela; A G Redeker; V M Edwards; R Decker; L R Overby; J W Mosley
Journal:  Gastroenterology       Date:  1978-05       Impact factor: 22.682

5.  Epidemiology of non-A, non-B hepatitis.

Authors:  F Caredda; A D'Arminio Monforte; S Lopez; D Culrado; M Moroni
Journal:  Lancet       Date:  1979 Dec 22-29       Impact factor: 79.321

6.  Incidence and pathophysiology of pulmonary edema in fulminant hepatic failure.

Authors:  P N Trewby; R Warren; S Contini; W A Crosbie; S P Wilkinson; J W Laws; R Williams
Journal:  Gastroenterology       Date:  1978-05       Impact factor: 22.682

Review 7.  The management of fulminant hepatic failure.

Authors:  C Trey; C S Davidson
Journal:  Prog Liver Dis       Date:  1970

8.  Hepatitis B antigen (HBSAg) and/or antibodies (anti-HBS and anti-HBC) in fulminant hepatitis: pathogenic and prognostic significance.

Authors:  C G Trepo; D Robert; J Motin; D Trepo; M Sepetjian; A M Prince
Journal:  Gut       Date:  1976-01       Impact factor: 23.059

9.  Epidemiology and clinical characteristics of acute hepatitis types A, B, and non-A non-B.

Authors:  L R Mathiesen; P Skinhøj; F Hardt; J O Nielsen; K Sloth; H Zoffmann; A M Møller; D Wong; R H Purcell
Journal:  Scand J Gastroenterol       Date:  1979       Impact factor: 2.423

10.  Hepatitis type A, B, and non-A non-B in fulminant hepatitis.

Authors:  L R Mathiesen; P Skinoj; J O Nielsen; R H Purcell; D Wong; L Ranek
Journal:  Gut       Date:  1980-01       Impact factor: 23.059

View more
  34 in total

Review 1.  Considerations of HAV vaccine in India.

Authors:  P Mathur; N K Arora
Journal:  Indian J Pediatr       Date:  1999 Jan-Feb       Impact factor: 1.967

2.  The changing epidemiological pattern of hepatitis A in an urban population of India: emergence of a trend similar to the European countries.

Authors:  K Das; A Jain; S Gupta; S Kapoor; R K Gupta; A Chakravorty; P Kar
Journal:  Eur J Epidemiol       Date:  2000-06       Impact factor: 8.082

3.  Seroepidemiology of hepatitis A in Delhi.

Authors:  A K Dutta; A Aggarwal; A K Kapoor; G N Ray; S Batra
Journal:  Indian J Pediatr       Date:  2000-02       Impact factor: 1.967

4.  Detection of immunoglobulin M antibodies to hepatitis E virus by class capture enzyme immunoassay.

Authors:  C Yu; R E Engle; J P Bryan; S U Emerson; R H Purcell
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

5.  Making a case for hepatitis a vaccination in glucose -6 phosphate dehydrogenase deficient subjects.

Authors:  Deepa Sharma; Anupam Sibal
Journal:  Indian J Pediatr       Date:  2005-07       Impact factor: 1.967

6.  Epidemiology of childhood hepatitis B in India: vaccination related issues.

Authors:  L Kant; A J Hall
Journal:  Indian J Pediatr       Date:  1995 Nov-Dec       Impact factor: 1.967

7.  Outbreak of viral hepatitis B in a rural community in India linked to inadequately sterilized needles and syringes.

Authors:  J Singh; R Bhatia; J C Gandhi; A P Kaswekar; S Khare; S B Patel; V B Oza; D C Jain; J Sokhey
Journal:  Bull World Health Organ       Date:  1998       Impact factor: 9.408

8.  EPIDEMIOLOGICAL PROFILE OF HOSPITALIZED VIRAL HEPATITIS CASES.

Authors:  R K Gupta
Journal:  Med J Armed Forces India       Date:  2017-06-26

9.  Hepatitis B virus among Saudi children in Gizan, Saudi Arabia.

Authors:  C M Parande; S C Arya; S J Ashraf
Journal:  Infection       Date:  1986 Sep-Oct       Impact factor: 3.553

10.  Preventing Post-Transfusion Hepatitis by screening blood donors for IgM Antibody to Hepatitis B core antigen.

Authors:  Nilima G Sawke; Gk Sawke
Journal:  J Glob Infect Dis       Date:  2010-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.